ArticleFoods (Basel, Switzerland)2026
Comparative Bioaccessibility of Phenolic Compounds from Almonds, Peanuts, Pistachios and Their Corresponding Butters.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nuts are an important dietary source of phenolic compounds, which are associated with potential health benefits. In the present study, the bioaccessibility of phenolic compounds from almonds, peanuts, pistachios and their corresponding butters was investigated after in vitro gastro-intestinal digestion. High-resolution mass spectrometry analysis provided a comprehensive picture of the phenolic profiles across samples, with a total of 55-95 compounds identified per matrix. Pistachios showed the highest amount of phenolic compounds (60.603 ± 1.170 mg/100 g), followed by peanuts and almonds. Processing into butter affected phenolic concentration in a matrix-specific manner. Almond and peanut butters showed higher phenolic content compared to whole nuts, whereas pistachio butter exhibited lower levels than the whole nut. After digestion, differences in bioaccessibility were observed. Peanuts showed the highest phenolic bioaccessibility (84.31%), while almonds and pistachios exhibited lower values (<15%). Overall, phenolic bioaccessibility was mainly influenced by nut type and phenolic compound structure, rather than by their initial concentration or processing. These findings are based on an in vitro model representing an estimate of bioaccessibility rather than in vivo absorption. However, nut type and processing appear to influence the release of phenolic compounds, which is relevant for the nutritional evaluation of nuts and nut-derived products.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.